Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Esperion Therapeutics Inc (NASDAQ:ESPR)

During the Trading Day
61.92 +1.07 / +1.76%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
61.92 0.00 / 0.00%
 
Volume: 7.9K

Today’s Trading

Previous close60.85
Today’s open60.62
Day’s range59.77 - 62.24
Volume787,455
Average volume (3 months)1,026,703
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+32.93%
Earnings growth (this year)-13.49%
Earnings growth (next 5 years)-21.89%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.27

Competitors

 Today’s
change
Today’s
% change
RLYPRelypsa Inc+0.18+0.54%
CHRSCoherus Biosciences ...-0.36-1.03%
MNTAMomenta Pharmaceutic...+0.29+1.33%
IMGNImmunoGen Inc-0.30-1.80%
Data as of 3:59pm ET, 08/04/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$0.00
Annual profit (last year)-$36.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Scientific Officer
Roger S. Newton
President, Chief Executive Officer &
Director
Tim M. Mayleben
Corporate headquarters
Ann Arbor, Michigan

Forecasts